Implementation of Home Monitoring in Patients with Pulmonary Fibrosis

Last updated: March 13, 2025
Sponsor: Erasmus Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cystic Fibrosis

Lung Disease

Scar Tissue

Treatment

Home monitoring care

Clinical Study ID

NCT06883448
MEC-2024-0045
10140292110006
  • Ages > 18
  • All Genders

Study Summary

The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • A multidisciplinary ILD team diagnosis of pulmonary fibrosis according toATS/ERS/JRS/ALAT guidelines;

  • Adults (=/>18 years).

Exclusion

Exclusion Criteria:

  • Patients who are not able to speak, read and/or write in Dutch;

  • Patients with no access to the internet;

  • Patients with a life expectancy of less than 1 year as determined by the treatinghealthcare provider;

  • Patients who are or have been using a home monitoring program for PF.

Study Design

Total Participants: 220
Treatment Group(s): 1
Primary Treatment: Home monitoring care
Phase:
Study Start date:
October 02, 2024
Estimated Completion Date:
September 01, 2026

Study Description

Patients will be randomly assigned to receive either hospital-based care or a home monitoring program integrated into hospital-based care. Hospital-based care involves outpatient clinic visits every three months including lung function testing. Home monitoring involves weekly measurements of both physiological- and patient reported outcomes (PROs) in a mobile health care application with half of the outpatient clinic visits alternately being replaced by remote video consultations. The home monitoring program includes home spirometry, pulse-oximetry, PROs, video consultations, a medication coach, and an infotheque showing disease-specific information. Questionnaires will be filled out by both study groups at set time points. The total study duration for individual patients will be 12 months.

Connect with a study center

  • Department of Pulmonology, Onze Lieve Vrouwe Gasthuis

    Amsterdam,
    Netherlands

    Active - Recruiting

  • Department of Pulmonary Diseases, Rijnstate Hospital

    Arnhem,
    Netherlands

    Active - Recruiting

  • Department of Respiratory Medicine, Amphia Hospital

    Breda,
    Netherlands

    Active - Recruiting

  • Department of Pulmonology, Haaglanden Medisch Centrum

    Den Haag,
    Netherlands

    Active - Recruiting

  • Department of Respiratory Medicine, Catharina Hospital

    Eindhoven,
    Netherlands

    Active - Recruiting

  • Department of Pulmonary Medicine, Zuyderland Medical Centre

    Heerlen,
    Netherlands

    Site Not Available

  • Department of Pulmonology, Medical Center Leeuwarden

    Leeuwarden,
    Netherlands

    Active - Recruiting

  • Department of Pulmonology, Leiden University Medical Center

    Leiden,
    Netherlands

    Active - Recruiting

  • Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital

    Nieuwegein,
    Netherlands

    Site Not Available

  • Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center

    Rotterdam,
    Netherlands

    Active - Recruiting

  • Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University

    Utrecht,
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.